Christopher Bowden
Director/Board Member presso Cedilla Therapeutics, Inc.
Profilo
Christopher J.
Bowden is on the board of Cedilla Therapeutics, Inc.
Dr. Bowden previously held the position of Chief Medical Officer of Agios Pharmaceuticals, Inc., Executive Director-Europe, Middle East & Africa at Bristol Myers Squibb Co., VP-Product Development Oncology at Genentech, Inc. and Member of Roche Group.
Christopher J.
Bowden received a doctorate from Drexel University College of Medicine and an undergraduate degree from Lake Forest College.
Posizioni attive di Christopher Bowden
Società | Posizione | Inizio |
---|---|---|
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Director/Board Member | 21/04/2021 |
Precedenti posizioni note di Christopher Bowden
Società | Posizione | Fine |
---|---|---|
ALAUNOS THERAPEUTICS, INC. | Director/Board Member | 30/03/2023 |
AGIOS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/09/2021 |
VIRIDIAN THERAPEUTICS, INC. | Director/Board Member | 01/10/2020 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/05/2014 |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01/01/2014 |
Formazione di Christopher Bowden
Lake Forest College | Undergraduate Degree |
Drexel University College of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
AGIOS PHARMACEUTICALS, INC. | Health Technology |
ALAUNOS THERAPEUTICS, INC. | Health Technology |
VIRIDIAN THERAPEUTICS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Health Technology |